Departments of1Interventional Neuroradiology and.
3University of Limoges, CNRS, XLIM, UMR 7252, Limoges, France.
J Neurosurg. 2018 Apr;128(4):982-991. doi: 10.3171/2016.11.JNS161020. Epub 2017 Jun 9.
OBJECTIVE Even though published data exist concerning the prevalence of ischemic lesions detected by diffusion-weighted imaging (DWI) following endovascular treatment of intracranial aneurysms, a single-center cross-evaluation of the different endovascular techniques has been lacking. The authors sought to prospectively evaluate the prevalence and clinical significance of ischemic lesions occurring after endovascular treatment of intracranial aneurysms and to compare the safety and effectiveness of a broad spectrum of currently accepted endovascular techniques in a single-center setting. METHODS This was a prospective cohort study involving consecutive patients treated for intracranial aneurysms exclusively by endovascular means, excluding treatments in the acute rupture phase, in a center featuring an endovascular-only treatment policy for intracranial aneurysms. All patients underwent MRI, including a 3-directional DWI sequence, before treatment, 24 hours postprocedure, and 6 months following endovascular embolization. Selective angiography was performed at 6 months' follow-up. RESULTS From January 2012 through December 2013, 164 aneurysms were treated in 128 consecutive patients. Endovascular techniques included coiling (14.6%), balloon-assisted coiling (20.1%), stent-assisted coiling (3.7%), low-profile stent-assisted coiling, flow diversion (38.4%), and very complex treatments (6.1%) involving 2 stents in Y or T configurations. On postprocedure MRI, the rates of occurrence of new DWI-positive lesions were 64.3% for coiling, 54.5% for remodeling, 61.1% for stent-assisted coiling, 53.7% for flow-diverting stents, and 75% for very complex treatments (p = 0.4962). The 6-month procedure-related morbidity and mortality rates were 6.25% and 0%, respectively. At 6 months' follow-up, 93% of the patients had modified Rankin Scale (mRS) scores of 0-2. Very complex treatments offered a higher complete occlusion rate (100%) than all other techniques (66.7%-88.9%). Age and length of procedure were independent factors for DWI lesion occurrence. The diameter of DWI lesions on 24-hour postprocedure MRI was positively correlated with mRS score at discharge. Among the DWI-positive lesions measuring less than 2 mm in diameter on the 24-hour MRI, 44.12% had regressed at 6 months. CONCLUSIONS Procedure-related DWI lesions are far more often encountered in silent forms than they are clinically evident. They do not seem to be significantly correlated with procedure-related complications, nor do they seem to impair clinical outcome, regardless of the endovascular technique. Small lesions (< 2 mm in diameter) may regress within 6 months. The use of the most adapted technique, in terms of aneurysm configuration, results in significant total occlusion rates, with acceptable safety.
尽管已有关于血管内治疗颅内动脉瘤后弥散加权成像(DWI)检测到缺血性病变的发表数据,但缺乏对不同血管内技术的单中心交叉评估。作者旨在前瞻性评估颅内动脉瘤血管内治疗后发生缺血性病变的发生率和临床意义,并在单中心环境中比较目前广泛接受的各种血管内技术的安全性和有效性。
这是一项前瞻性队列研究,纳入了 2012 年 1 月至 2013 年 12 月期间,在以血管内治疗颅内动脉瘤为唯一治疗方法的中心,连续接受颅内动脉瘤血管内治疗的患者(排除急性期破裂的治疗)。所有患者在治疗前、术后 24 小时和血管内栓塞后 6 个月进行 MRI 检查,包括三维 DWI 序列。选择性血管造影在 6 个月时进行。
2012 年 1 月至 2013 年 12 月期间,128 例连续患者的 164 个动脉瘤接受了治疗。血管内技术包括线圈(14.6%)、球囊辅助线圈(20.1%)、支架辅助线圈(3.7%)、低剖面支架辅助线圈、血流导向(38.4%)和非常复杂的治疗(6.1%),涉及 Y 或 T 构型的 2 个支架。术后 MRI 上,线圈的新 DWI 阳性病变发生率为 64.3%,重塑为 54.5%,支架辅助线圈为 61.1%,血流导向支架为 53.7%,非常复杂的治疗为 75%(p=0.4962)。6 个月的手术相关发病率和死亡率分别为 6.25%和 0%。6 个月随访时,93%的患者改良 Rankin 量表(mRS)评分为 0-2 分。非常复杂的治疗比所有其他技术(66.7%-88.9%)提供更高的完全闭塞率(100%)。年龄和手术时间是 DWI 病变发生的独立因素。术后 24 小时 MRI 上 DWI 病变的直径与出院时 mRS 评分呈正相关。在术后 24 小时 MRI 上直径小于 2 毫米的 DWI 阳性病变中,44.12%在 6 个月时已消退。
与临床上明显的病变相比,与手术相关的 DWI 病变更常以无症状形式出现。无论采用何种血管内技术,它们似乎与手术相关的并发症没有明显的相关性,也似乎不会影响临床结局。直径小于 2 毫米的小病变(<2 毫米)可能在 6 个月内消退。使用最适合动脉瘤形态的技术可显著提高完全闭塞率,同时保持可接受的安全性。